Benefits of cyclosporine microemulsion (Neoral) C2 monitoring are sustained at 1 year in de novo liver transplant recipients

被引：17

作者：

Lake, JR ^{[1
]}

机构：

[1] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA

来源：

TRANSPLANTATION PROCEEDINGS | 2001年 / 33卷 / 7-8期

关键词：

D O I：

10.1016/S0041-1345(01)02317-X

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

收藏

页码：3092 / 3093

页数：2

相关论文

共 4 条

[1] Peak cyclosporine levels (Cmax) correlate with freedom from liver graft rejection -: Results of a prospective, randomized comparison of neoral and sandimmune for liver transplantation (NOF-8)
Grant, D
Kneteman, N
Tchervenkov, J
Roy, A
Murphy, G
Tan, A
Hendricks, L
Guilbault, N
Levy, G
[J]. TRANSPLANTATION, 1999, 67 (08) : 1133 - 1137
[2] Neoral compared to sandimmune is associated with a decrease in histologic severity of rejection in patients undergoing primary liver transplantation
Graziadei, IW
Wiesner, RH
Marotta, PJ
Porayko, MK
Dahlke, LJ
Wilson, SM
Steers, JL
Krom, RAF
[J]. TRANSPLANTATION, 1997, 64 (05) : 726 - 731
[3] MULLER EA, 1994, PHARM RES-DORDR, V11, P301
[4] Acute hepatic allograft rejection: Incidence, risk factors, and impact on outcome
Wiesner, RH
Demetris, AJ
Belle, SH
Seaberg, EC
Lake, JR
Zetterman, RK
Everhart, J
Detre, KM
[J]. HEPATOLOGY, 1998, 28 (03) : 638 - 645